CSIMarket Company Name, Ticker, Suppliers, else..


Clovis Oncology inc   (CLVS)
Other Ticker:  
 

Clovis Oncology inc

CLVS's Fundamental analysis



Clovis Oncology Inc 's sales fell by -19.13 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 3506

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.12 %

Clovis Oncology Inc net loss deacreased by in III. Quarter 2022 year on year, Clovis Oncology Inc net loss increased by -16.91 % in III. Quarter 2022 year on year,

• More on CLVS's Growth


Clovis Oncology Inc
realized net loss in trailing twelve months.

Clovis Oncology Inc realized cash outflow of $ -0.79per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
351.12
PE TTM    
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.


• More on CLVS's Valuation
 
 Total Debt (Millions $) 438
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 288,549
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.77
 Tangible Book Value (Per Share $) -3.72

Clovis Oncology Inc
realized net loss in trailing twelve months.

Clovis Oncology Inc realized cash outflow of $ -0.79per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
351.12
PE TTM    
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.


• More on CLVS's Valuation

•  Market Capitalization (Millions $) 12
•  Shares Outstanding (Millions) 145
•  Employees 461
•  Revenues (TTM) (Millions $) 133
•  Net Income (TTM) (Millions $) -252
•  Cash Flow (TTM) (Millions $) -114
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) 438
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 288,549
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.77
•  Tangible Book Value (Per Share $) -3.72

•  Market Capitalization (Millions $) 12
•  Shares Outstanding (Millions) 145
•  Employees 461
•  Revenues (TTM) (Millions $) 133
•  Net Income (TTM) (Millions $) -252
•  Cash Flow (TTM) (Millions $) -114
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 0.14
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.33
•  Inventory Turnover Ratio (TTM) 2.39





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com